Bio-Key International (NASDAQ:BKYI) insider Fong Wong Kwok purchased 91,820 shares of the business’s stock in a transaction on Tuesday, April 3rd. The shares were bought at an average price of $3.60 per share, for a total transaction of $330,552.00. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website.
NASDAQ BKYI traded up $0.06 during trading hours on Friday, hitting $2.24. 32,412 shares of the company were exchanged, compared to its average volume of 27,554. Bio-Key International has a 52-week low of $1.20 and a 52-week high of $3.67.
Bio-Key International (NASDAQ:BKYI) last issued its quarterly earnings results on Thursday, March 29th. The technology company reported $0.04 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.02) by $0.06. Bio-Key International had a negative return on equity of 31.36% and a negative net margin of 67.52%. The company had revenue of $3.06 million for the quarter.
TRADEMARK VIOLATION WARNING: “Bio-Key International (BKYI) Insider Fong Wong Kwok Acquires 91,820 Shares of Stock” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at https://www.tickerreport.com/banking-finance/3335251/bio-key-international-bkyi-insider-fong-wong-kwok-acquires-91820-shares-of-stock.html.
About Bio-Key International
BIO-key International, Inc develops and markets fingerprint biometric identification and identity verification technologies, authentication-transaction security technologies, and related identity management and credentialing biometric hardware and software solutions. Its solutions enable application developers, value added resellers, and channel partners to integrate fingerprint biometrics into their application.
Receive News & Ratings for Bio-Key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Key International and related companies with MarketBeat.com's FREE daily email newsletter.